Shinagawa-ku, Japan

Mitsuhiro Makino

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):

Title: Mitsuhiro Makino: Innovator in Pharmaceutical Compounds

Introduction

Mitsuhiro Makino is a notable inventor based in Shinagawa-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating central inflammatory diseases. With a total of 2 patents to his name, Makino's work is recognized for its potential impact on medical treatments.

Latest Patents

One of his latest patents is focused on a Griseofulvin compound and its pharmaceutical use. This invention addresses the need for a compound that can be used for the prophylaxis and treatment of central inflammatory diseases. The patent describes a compound of a general formula (I) or a pharmacologically acceptable salt thereof, which aims to solve this medical issue. The compound includes various alkyl groups and a 5-membered aromatic hetero-ring, showcasing the complexity and innovation behind his work.

Career Highlights

Mitsuhiro Makino is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His career is marked by a commitment to improving healthcare through innovative pharmaceutical solutions.

Collaborations

Makino has collaborated with esteemed colleagues such as Keiji Saito and Katsuyoshi Nakajima. These partnerships have likely contributed to the success of his inventions and the advancement of their shared goals in the pharmaceutical industry.

Conclusion

Mitsuhiro Makino stands out as a dedicated inventor in the pharmaceutical field, with a focus on developing innovative compounds for treating significant health issues. His contributions are paving the way for advancements in medical treatments, and his work continues to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…